These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24816159)

  • 1. Study of in vitro metabolism of m-nisoldipine in human liver microsomes and recombinant cytochrome P450 enzymes by liquid chromatography-mass spectrometry.
    Yuan L; Jia P; Sun Y; Zhao C; Zhi X; Sheng N; Zhang L
    J Pharm Biomed Anal; 2014 Aug; 97():65-71. PubMed ID: 24816159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the in vitro stereoselective metabolism of m-nisoldipine enantiomers: characterization of metabolites and cytochrome P450 isoforms involved.
    Sun Y; Jia P; Yuan L; Liu Y; Zhang Z; Du Y; Zhang L
    Biomed Chromatogr; 2015 Dec; 29(12):1893-900. PubMed ID: 25994315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of in-vitro metabolism of selected antibiotic drugs in human liver microsomes by liquid chromatography coupled with tandem mass spectrometry.
    Szultka-Mlynska M; Buszewski B
    Anal Bioanal Chem; 2016 Nov; 408(29):8273-8287. PubMed ID: 27704178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
    Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
    Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
    Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
    Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.
    Qin CZ; Ren X; Tan ZR; Chen Y; Yin JY; Yu J; Qu J; Zhou HH; Liu ZQ
    Biomed Chromatogr; 2014 Feb; 28(2):197-203. PubMed ID: 23946123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of in vitro metabolites of luotonin A in human liver microsomes using electrospray/tandem mass spectrometry.
    Lee S; Lee J; Jahng Y; Jeong TC; Kim DH
    Xenobiotica; 2013 Jun; 43(6):527-33. PubMed ID: 23256623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
    Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s.
    Joo J; Wu Z; Lee B; Shon JC; Lee T; Lee IK; Sim T; Kim KH; Kim ND; Kim SH; Liu KH
    Biopharm Drug Dispos; 2015 Apr; 36(3):163-73. PubMed ID: 25451157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative metabolism of tussilagone in rat and human liver microsomes using ultra-high-performance liquid chromatography coupled with high-resolution LTQ-Orbitrap mass spectrometry.
    Zhang XS; Ren W; Bian BL; Zhao HY; Wang S
    Rapid Commun Mass Spectrom; 2015 Sep; 29(18):1641-50. PubMed ID: 26467116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
    Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
    Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of m-nisoldipine and its three metabolites in rat plasma by liquid chromatography-mass spectrometry.
    Kong D; Li S; Zhang X; Gu J; Liu M; Meng Y; Fu Y; La X; Xue G; Zhang L; Wang Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2989-96. PubMed ID: 20870469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes.
    Li W; Liu Y; He YQ; Zhang JW; Gao Y; Ge GB; Liu HX; Huo H; Liu HT; Wang LM; Sun J; Wang Q; Yang L
    Xenobiotica; 2008 Dec; 38(12):1551-65. PubMed ID: 18982531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated liquid chromatography-tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases.
    Lee JT; Pao LH; Hsiong CH; Huang PW; Shih TY; Yoa-Pu Hu O
    Talanta; 2013 Mar; 106():220-8. PubMed ID: 23598120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.
    Zeng J; Fan YJ; Tan B; Su HZ; Li Y; Zhang LL; Jiang J; Qiu FR
    Acta Pharmacol Sin; 2018 Aug; 39(8):1393-1404. PubMed ID: 29417949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of in vitro metabolites of TM-2, a potential antitumor drug, in rat, dog and human liver microsomes using liquid chromatography/tandem mass spectrometry.
    Men L; Zhao Y; Lin H; Yang M; Liu H; Tang X; Yu Z
    Rapid Commun Mass Spectrom; 2014 Oct; 28(20):2162-70. PubMed ID: 25178720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of ten cytochrome P450 enzyme activities with 12 probe substrates in human liver microsomes using cocktail incubation and liquid chromatography-tandem mass spectrometry.
    Kim HJ; Lee H; Ji HK; Lee T; Liu KH
    Biopharm Drug Dispos; 2019 Apr; 40(3-4):101-111. PubMed ID: 30730576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
    Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of α-thujone in human hepatic preparations in vitro.
    Abass K; Reponen P; Mattila S; Pelkonen O
    Xenobiotica; 2011 Feb; 41(2):101-11. PubMed ID: 21087116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of in vitro metabolites of the new anticancer agent EAPB0503 by liquid chromatography-tandem mass spectrometry.
    Lafaille F; Solassol I; Enjalbal C; Bertrand B; Doulain PE; Vappiani J; Bonnet PA; Deleuze-Masquéfa C; Bressolle FM
    J Pharm Biomed Anal; 2014 Jan; 88():429-40. PubMed ID: 24176748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.